Oxalic Acid

Oxalic Acid

SCHEMBL9309780

Cn1c(N2CCN(C(CO)CCc3ccccc3)CC2)cc(=O)n(C)c1=O.O=C(O)C(=O)O

nearest known ligand 0.45

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

OPRM1SLC6A4

The experimentally established mechanism targets of Oxalic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 1/20 0.45
ALDH1A1 P00352 3/20 0.43
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
HRH1 P35367 10/20 0.41
MC4R P32245 1/20 0.41
ADRA1D P25100 1/20 0.41
ADRA1A P35348 1/20 0.41
ADRA1B P35368 1/20 0.41
TAAR1 Q96RJ0 1/20 0.40
KDM4E B2RXH2 1/20 0.39
TP53 P04637 1/20 0.39
ADA P00813 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9309083 0.97 IDO1 (0.48) IDO1ALDH1A1MEN1KMT2ANPC1
Oxalic Acid SCHEMBL9311425 0.90 IDO1 (0.57) IDO1ALDH1A1MEN1KMT2ANPC1
SCHEMBL9310694 0.87 IDO1 (0.61) IDO1ALDH1A1MEN1KMT2ASMN1; SMN2
SCHEMBL9309785 0.85 ALDH1A1 (0.41) ALDH1A1MEN1KMT2ANPC1RAB9A
Oxalic Acid SCHEMBL9309837 0.82 ALDH1A1 (0.40) ALDH1A1MEN1KMT2ANPC1RAB9A
SCHEMBL9309862 0.79 ALDH1A1 (0.41) ALDH1A1MEN1KMT2ANPC1RAB9A
SCHEMBL9309825 0.79 ALDH1A1 (0.46) ALDH1A1MEN1KMT2ANPC1RAB9A
Hydrochloric Acid SCHEMBL9309600 0.78 ALDH1A1 (0.45) ALDH1A1MEN1KMT2ANPC1RAB9A
SCHEMBL9309553 0.77 IDO1 (0.45) IDO1ALDH1A1MEN1KMT2AHRH1
Oxalic Acid SCHEMBL9311070 0.76 HRH1 (0.46) ALDH1A1MEN1KMT2ASMN1; SMN2HRH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5308848-A Side effect reduction MITSUI TOATSU CHEMICALS, INCORPORATED (JP) 1994-05-03 US disclosed
EP-0452107-A1 Pyrimidinedione derivatives and antiarrythmic agents containing same MITSUI TOATSU CHEMICALS, Inc. (JP) 1991-10-16 EP disclosed